Dr Reddy's gains 3% on USFDA nod for launch of generic version of Suboxone

In past eight trading sessions, the stock of pharmaceutical company has rallied 20% from Rs 1,960 on June 5, 2018, as compared to 2% rise in the S&P BSE Sensex.

from Latest News https://ift.tt/2JIV9im